0001213900-20-002859.txt : 20200310 0001213900-20-002859.hdr.sgml : 20200310 20200207103257 ACCESSION NUMBER: 0001213900-20-002859 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20200207 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Can-Fite BioPharma Ltd. CENTRAL INDEX KEY: 0001536196 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 10 BAREKET STREET, KIRYAT MATALON STREET 2: P.O. BOX 7537 CITY: PETACH TIKVA STATE: L3 ZIP: 4951778 BUSINESS PHONE: 972 39241114 MAIL ADDRESS: STREET 1: 10 BAREKET STREET, KIRYAT MATALON STREET 2: P.O. BOX 7537 CITY: PETACH TIKVA STATE: L3 ZIP: 4951778 CORRESP 1 filename1.htm

Can-Fite BioPharma Ltd.

10 Bareket Street

Kiryat Matalon, P.O. Box 7537

Petach-Tikva 4951778, Israel

 

February 7, 2020

 

Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549

 

Re: Can-Fite BioPharma Ltd.
 

Withdrawal of Acceleration Request - Registration Statement on Form F-1

File No. 333-236064

 

VIA EDGAR

 

Ladies and Gentlemen:

 

Can-Fite BioPharma Ltd. hereby withdraws its acceleration request letter dated February 4, 2020, which requested that the effective date of the Registration Statement on Form F-1 referenced above be accelerated so that it would have become effective at 9:00 a.m. on February 5, 2020 or as soon thereafter as may be practicable.

 

 

  

  Very truly yours,
   
  CAN-FITE BIOPHARMA LTD.
   
  By: /s/ Pnina Fishman, Ph.D.
    Name: Pnina Fishman, Ph.D.
    Title:   Chief Executive Officer

 

cc: Gary Emmanuel (McDermott Will & Emery LLP)